160 related articles for article (PubMed ID: 26397980)
1. Ifosfamide-induced encephalopathy due to a novel formulation of ifosfamide.
Filhon B; Lacarra B; Hervouet C; Jaffray M; Schneider P; Vannier JP
Pediatr Blood Cancer; 2016 Feb; 63(2):372-3. PubMed ID: 26397980
[No Abstract] [Full Text] [Related]
2. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
[TBL] [Abstract][Full Text] [Related]
3. [Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients].
Stern N; Sakji I; Defachelles AS; Lervat C; Ryckewaert T; Marliot G; Peugniez C; Deplanque D; Penel N
Bull Cancer; 2017 Mar; 104(3):208-212. PubMed ID: 27986268
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide induced encephalopathy in a child with osteosarcoma.
Sarbay H; Demir ÜF; Yılmaz G; Atay AA; Malbora B
J Oncol Pharm Pract; 2021 Jul; 27(5):1302-1306. PubMed ID: 33023384
[TBL] [Abstract][Full Text] [Related]
5. [Methylene blue in ifosfamide-induced encephalopathy].
Koschuth A; Späth-Schwalbe PE; Possinger K
Dtsch Med Wochenschr; 1996 Sep; 121(39):1210. PubMed ID: 8925751
[No Abstract] [Full Text] [Related]
6. Ifosfamide induced encephalopathy following chemotherapy of Non-Hodgkin's Lymphoma.
Jain S; Moger V; Kumari S; Varma S
Neurol India; 2001 Dec; 49(4):416. PubMed ID: 11799423
[No Abstract] [Full Text] [Related]
7. Treatment of ifosfamide encephalopathy with intravenous thiamin.
Buesa JM; García-Teijido P; Losa R; Fra J
Clin Cancer Res; 2003 Oct; 9(12):4636-7. PubMed ID: 14555540
[No Abstract] [Full Text] [Related]
8. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
Sweiss KI; Beri R; Shord SS
Drug Saf; 2008; 31(11):989-96. PubMed ID: 18840018
[TBL] [Abstract][Full Text] [Related]
9. The Use of Continuous Veno-Venous Hemodiafiltration in the Management of Ifosfamide-induced Encephalopathy: A Case Report.
Yeo KK; HaDuong JH
J Pediatr Hematol Oncol; 2016 Aug; 38(6):489-90. PubMed ID: 26907647
[TBL] [Abstract][Full Text] [Related]
10. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide-induced encephalopathy and movement disorder.
Ames B; Lewis LD; Chaffee S; Kim J; Morse R
Pediatr Blood Cancer; 2010 Apr; 54(4):624-6. PubMed ID: 19953647
[TBL] [Abstract][Full Text] [Related]
12. [Ifosfamide induced encephalopathy: 15 observations].
Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide encephalopathy associated with chemotherapy for musculoskeletal sarcomas: incidence, severity, and risk factors.
Tajino T; Kikuchi S; Yamada H; Takeda A; Konno S
J Orthop Sci; 2010 Jan; 15(1):104-11. PubMed ID: 20151259
[TBL] [Abstract][Full Text] [Related]
14. [The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Tominaga T
No Shinkei Geka; 2010 Nov; 38(11):997-1005. PubMed ID: 21081811
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment with methylene blue of ifosfamide-induced central nervous system effects].
Demandt M; Wandt H
Dtsch Med Wochenschr; 1996 Apr; 121(17):575. PubMed ID: 8620831
[No Abstract] [Full Text] [Related]
16. Ifosfamide related encephalopathy: the need for a timely EEG evaluation.
Feyissa AM; Tummala S
J Neurol Sci; 2014 Jan; 336(1-2):109-12. PubMed ID: 24209900
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy.
Durand JP; Gourmel B; Mir O; Goldwasser F
Ann Oncol; 2007 Apr; 18(4):808-9. PubMed ID: 17389531
[No Abstract] [Full Text] [Related]
18. Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.
Cherry MA; Bhardwaj H; Hopps S; Srour S; Pant S
J Oncol Pharm Pract; 2013 Sep; 19(3):261-4. PubMed ID: 23135805
[TBL] [Abstract][Full Text] [Related]
19. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
[TBL] [Abstract][Full Text] [Related]
20. [Ifosfamide].
Manegold C
Zentralbl Gynakol; 1996; 118(10):580-1. PubMed ID: 8999718
[No Abstract] [Full Text] [Related]
[Next] [New Search]